SCHEMBL30906392

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O

nearest known ligand 0.71

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	9/20	0.61

▸	NPY4R	P50391	8/20	0.61

▸	NPY5R	Q15761	8/20	0.61

▸	NPY1R	P25929	7/20	0.61

▸	EP300	Q09472	1/20	0.58

▸	HIF1A	Q16665	1/20	0.58

▸	TFPI	P10646	2/20	0.57

▸	CALCR	P30988	4/20	0.56

▸	GLP1R	P43220	2/20	0.56

▸	MAPK8	P45983	1/20	0.56

▸	MAPK9	P45984	1/20	0.56

▸	MAPK10	P53779	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906560	1.00	NPY2R (0.61)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30726570	0.92	NPY2R (0.62)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30495779	0.91	NPY2R (0.65)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31182572	0.90	NPY2R (0.62)	NPY2RNPY4RNPY5RNPY1RMAPK8
SCHEMBL31182683	0.90	NPY2R (0.71)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL31182717	0.89	CALCR (0.68)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30607389	0.89	NPY2R (0.57)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL31730324	0.89	CXCR4 (0.60)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30712955	0.89	NPY2R (0.58)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30495665	0.89	CALCR (0.65)	NPY2RNPY4RNPY5RNPY1REP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed